Closed Blood Sampling System MarketSize and Trends

Closed Blood Sampling System Market Drivers

Increasing number of surgical procedures is a major factor driving growth of global closed blood sampling system market. According to the estimation of the World Health Organization, 266.2 to 359.5 million surgeries were performed in 2012, which was around 38% higher as compared to the previous years and is expected to increase in the near future. Therefore, increasing number of surgeries and emergency cases, and high demand for blood transfusion increases the demand for closed blood sampling system. Moreover, studies by the National Center for Biotechnology Information (NCBI) reported that the patients admitted in ICU are majorly anemic and around 30 - 37% of the patients receive blood transfusion while admitted in ICU, which also shows the rising need for closed blood sampling system.

Furthermore, increasing cases of trauma and certain disease conditions such as cancer, HIV/AIDS, diabetes, coronary heart disease, rare diseases, and anemia are factors driving growth of closed blood sampling system market. According to the Centers for Disease Control and Prevention (CDC) 2016 data findings, 26,203 cases of Lyme disease were reported in the U.S. between 2006 and 2016. According to CDC, in 2015, around 10,265 deaths were reported due to alcohol-impaired driving crashes, which accounted for around 29% of all the traffic-related deaths in the U.S.

In critically ill patients and patients under observation in ICU, blood sampling is frequently done to monitor the hemodynamics. In conventional blood sampling systems, the blood sample is withdrawn by removal of stopcock cap, which increases the risk of acquired blood stream infection during sampling. Moreover, the unused blood is wasted in the case of conventional sampling method. Closed blood sampling system is a solution to these problems. Furthermore, the National Center for Biotechnology Information (NCBI) article suggests that the hemoglobin and hematocrit counts shows minimal fluctuations when blood sampling is done by closed blood sampling system.

Closed blood sampling systems are also used in pediatric patients, owing to easy implementation, low cost, and significant reduction in blood loss. The patients in the intensive care units (ICU) receive blood transfusion to treat low hemoglobin levels in patients with critical illness. However, improper blood transfusion methods are mostly associated with increased risk of morbidity and mortality. Various government regulatory organizations have proposed guidelines to decrease the use of blood transfusions. For instance, the Canadian Medical Association (CMA) released guidelines in 2008 in their Canadian Medical Association Journal (CMAL), which was published in January 2008, to minimize the use of blood transfusion in critically ill patients and closed blood sampling systems would be a method for complying with these regulations.

Increasing demand for blood donations is also fueling the demand for closed blood sampling systems. For instance, according to the World Health Organization (WHO), 112.5 million blood donations were recorded globally and an increase of 10.7 million blood donations from unpaid donors were reported from 2008 to 2013. Furthermore, according to the American National Red Cross, around 7,000 units of platelets and 10,000 units of plasma are required daily in the U.S. and nearly 21 million blood components are transfused each year in the U.S.